Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

By Catalano Vincenzo   Vincenzi Bruno   Giordani Paolo   Graziano Francesco   Santini Daniele   Baldelli Anna   Alessandroni Paolo   Schiavon Gaia   Rossi David   Casadei Virginia   D’Emidio Silvia   Luzi Fedeli Stefano   Tonini Giuseppe   Fiorentini Giammaria  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 419-426

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

By Park Keon   Ahn Jin   Park Young   Lee Jeeyun   Kang Jung   Park Joon   Lim Ho   Im Young-Hyuck   Kang Won   Park Keunchil   Lee Soon  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 17-21

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel and cisplatin combination chemotherapy in anthracyclines-resistant advanced breast cancer

By Xiong Hailin   Liu Zhujun   Cheng Xin   Li Kai  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 1, 2007-02 ,pp. : 55-58

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study

By Constenla Manuel   Garcia-Arroyo Ramon   Lorenzo Isabel   Carrete Nancy   Campos Begoña   Palacios Patricia  

Gastric Cancer, Vol. 5, Iss. 3, 2002-09 ,pp. : 142-147

Springer Publishing Company

Access to resources Recommend Favorite

Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma

By Du Chengrun  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 464-471

Springer Publishing Company

Access to resources Recommend Favorite